Study on the Anti-HPA Antibodies Caused Neonatal Alloimmune Thrombocytopenia in Chinese Pregnant Women

Summary

This clinical study aims to investigate the anti-HPA antibodies caused neonatal alloimmune thrombocytopenia in Chinese pregnant women. The survey and data collect will help form an appropriate clinical screening procedure

Conditions

• Neonatal Alloimmune Thrombocytopenia

Interventions

PROCEDURE

Standard clinical treatment, including intravenous immunoglobulin and/or platelet transfusion

Observational study.

Sponsors & Collaborators

• Air Force Military Medical University, China

  collaborator OTHER

• Shengjing Hospital

  collaborator OTHER

• Qilu Hospital of Shandong University

  collaborator OTHER

• Second Xiangya Hospital of Central South University

  collaborator OTHER

• LanZhou University

  collaborator OTHER

• The First Affiliated Hospital of Bengbu Medical University

  collaborator OTHER

• The Affiliated Hospital Of Guizhou Medical University

  collaborator OTHER

• Sir Run Run Shaw Hospital

  collaborator OTHER

• Jilin University

  collaborator OTHER

• First Affiliated Hospital of Xinjiang Medical University

  collaborator OTHER

• People's Hospital of Xinjiang Uygur Autonomous Region

  collaborator OTHER

• Second Affiliated Hospital of Nanchang University

  collaborator OTHER

• Guangzhou First People's Hospital

  collaborator OTHER

• The Affiliated Hospital Of Southwest Medical University

  collaborator OTHER

• Beijing Chao Yang Hospital

  collaborator OTHER

• Qingdao University

  collaborator OTHER

• Peking University First Hospital

  collaborator OTHER

• RenJi Hospital

  collaborator OTHER

• First Affiliated Hospital of Harbin Medical University

  collaborator OTHER

• MCH Hospital of Yinchuan City

  collaborator UNKNOWN

• Henan Provincial People's Hospital

  collaborator OTHER

• Third Affiliated Hospital, Sun Yat-Sen University

  collaborator OTHER

• The First Affiliated Hospital of Guangdong Pharmaceutical University

  collaborator OTHER

• Xinqiao Hospital of Chongqing

  lead OTHER

Eligibility

Min Age

18 Years

Max Age

50 Years

Sex

FEMALE

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2017-01-31

Primary Completion

2019-12-31